Načítá se...
Mitigating risk in academic preclinical drug discovery
The number of academic drug discovery centres has grown considerably in recent years, providing new opportunities to couple the curiosity-driven research culture in academia with rigorous preclinical drug discovery practices used in industry. To fully realize the potential of these opportunities, it...
Uloženo v:
| Vydáno v: | Nat Rev Drug Discov |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6002840/ https://ncbi.nlm.nih.gov/pubmed/25829283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd4578 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|